Upstream Bio, Inc. Share Price
NASDAQ: UPB | Micro CapUpstream Bio, Inc. Stock Performance
Upstream Bio, Inc. Share Price Today
As of 18 September 2026, Upstream Bio, Inc.'s share price is $5.33. The stock opened at $5.48, compared to its previous close of $5.33. During today's trading session, Upstream Bio, Inc.'s share price traded between $5.24 and $5.48, with an average price of $5.36. Over the past 52 weeks, the stock has recorded a high of $33.58 and a low of $5.24. In terms of performance, Upstream Bio, Inc.'s share price has declined by 40.64% over the last six months and is down 71.69% on a year-on-year basis.
Upstream Bio, Inc. Share Price Chart
Upstream Bio, Inc. Quarterly Profit & Loss
All figures in USD
Upstream Bio, Inc. Annual Profit & Loss
All figures in USD
About Upstream Bio, Inc.
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. Its product candidate includes verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, as well as in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Upstream Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $6.54 | $5.32 | -21.65% |
Aug 2026 | $6.25 | $6.79 | +7.95% |
Jul 2026 | $6.95 | $6.29 | -9.04% |
Jun 2026 | $8.31 | $6.92 | -17.24% |
May 2026 | $9.21 | $8.36 | -8.89% |
Apr 2026 | $9.22 | $9.17 | +2.23% |
Mar 2026 | $7.58 | $8.97 | +16.64% |
Feb 2026 | $31.66 | $7.69 | -75.25% |
Jan 2026 | $27.09 | $31.07 | +14.29% |
Dec 2025 | $28.32 | $27.18 | -4.71% |
Nov 2025 | $25.84 | $28.53 | +10.41% |
Oct 2025 | $18.61 | $25.84 | +37.37% |